{"podcast":{"title":"Blunt Business","slug":"blunt-business-326858","podcast_index_feed_id":326858,"rss_url":"https://feeds.redcircle.com/6370efa4-01ee-4341-adc8-94112a86e8e5","website_url":"https://redcircle.com/shows/blunt-business1131","image_url":"https://media.redcircle.com/images/2026/1/7/5/83efac08-c3e8-48ab-99a9-2ed18dfcdf15_blunt_business_logo_2026.jpg","author":"Cannabis Radio","episode_count":473,"summary":"Dispensing Cannabis business knowledge beyond a million square feet of cultivation space. Blunt Business will navigate the challenges and opportunities of one of the most profitable industries on earth. Join us each episode to hear our weekly round tables and interviews with industry professionals.","last_synced_at":"2026-06-24T14:20:39.709364+00:00","page_url":"https://stenobird.com/podcast/blunt-business-326858"},"episode":{"title":"A Psychedelic and Cannabis Research Revolution On the Horizon?","slug":"a-psychedelic-and-cannabis-research-revolution-on-the-horizon","published_at":"2026-04-22T04:38:50+00:00","page_url":"https://stenobird.com/podcast/blunt-business-326858/a-psychedelic-and-cannabis-research-revolution-on-the-horizon","show_page_url":"https://stenobird.com/podcast/blunt-business-326858","url":"https://cannabisradio.com/audio/7919","audio_url":"https://audio3.redcircle.com/episodes/10d72e84-94e0-4ed2-893c-744ed3a848ca/stream.mp3","summary":"This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders. The newly signed executive order to direct the FDA to fast-track these compounds through new \"National Priority\" vouchers. Beyond psychedelics, the host discusses the impact of GLP-1 weight-loss drugs (like Ozempic) on the cannabis market, noting that dispensaries are seeing a shift in consumer preference toward lower-dose products to mitigate \"the munchies.\" Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy","meta_description":"This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psy…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1768,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blunt-business-326858/episodes/a-psychedelic-and-cannabis-research-revolution-on-the-horizon/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blunt-business-326858/a-psychedelic-and-cannabis-research-revolution-on-the-horizon.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}